Michelle Yoo Min Ko

Title: Michelle Yoo Min Ko: Innovator in G Protein-Coupled Receptor Modulators

Introduction

Michelle Yoo Min Ko is a prominent inventor based in San Francisco, CA. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target G protein-coupled receptors. With a total of two patents to her name, her work is paving the way for new therapeutic approaches.

Latest Patents

Michelle's latest patents include innovative methods for synthesizing trans isomeric forms of G protein-coupled receptor modulators. One patent discloses methods for the synthesis of a trans isomeric form of a C—C chemokine receptor type 4 (CCR4) modulator. This involves reacting specific compounds in the presence of a carboxylic acid directed reducing agent to achieve a predominantly trans isomerically pure form. Another patent focuses on pyrazole pyrimidine compounds that modulate and inhibit hematopoietic progenitor kinase 1, along with methods for making these compounds and their therapeutic applications.

Career Highlights

Michelle is currently employed at Rapt Therapeutics, Inc., where she continues to advance her research in pharmacology and drug development. Her work is characterized by a commitment to innovation and excellence in the field of biochemistry.

Collaborations

She collaborates with notable colleagues such as Cyril Bucher and Jeffrey J. Jackson, contributing to a dynamic research environment that fosters creativity and scientific advancement.

Conclusion

Michelle Yoo Min Ko is a trailblazer in her field, with her patents reflecting her dedication to developing new therapeutic solutions. Her contributions are significant in the ongoing quest for effective treatments targeting G protein-coupled receptors.